comparemela.com
  1. Home
  2. Live Updates
  3. Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older : comparemela.com

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Canada ,Canadian ,Intrahepatic Cholestasis ,Chris Peetz ,Instagram ,European Commission ,Committee For Orphan Medicinal Products ,Linkedin ,Drug Administration ,Mirum Pharmaceuticals Inc ,Nasdaq ,Health Canada ,Mirum Pharmaceuticals ,European Committee ,Medicinal Products ,Human Use ,Progressive Familial Intrahepatic Cholestasis ,Orphan Medicinal Products ,Orphan Drug Designation ,Breakthrough Therapy ,Fat Soluble Vitamin ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.